Chromos Molecular Systems has signed a contract with AppTec Laboratory Services for scale-up and manufacture of its monoclonal antibody drug product candidate CHR-1103. Chromos used its proprietary ACE System to engineer cell lines for CHR-1103. AppTec will scale up and manufacture CHR-1103 for use in preclinical toxicology studies and Phase I trials. “This contract is an important step forward in the development of CHR-1103,” said Alistair Duncan, president and chief executive ...